DaVita Inc. Logo

DaVita Inc. (DVA)

NYSE

Currency in USD
176.50
+2.68 (+1.54%)

Closed

Aug 24, 2026

Day's Range

171.40
177.16

52 wk Range

101.00
247.49

Overview - DVA - DaVita Inc.

Key Statistics

Valuation

Enterprise Value

25.65B

P/E (Trailing)

‪14.73‬

P/E (Forward)

‪10.21‬

PEG Ratio

‪0.26‬

Price / Sales (TTM)

‪0.79‬

Price / Book

‪10.59‬

EV / EBITDA

‪9.07‬

Profitability

Gross Margin

‪32.69%‬

Profit Margin

‪6.04%‬

Operating Margin

‪16.06%‬

Return on Assets

‪7.51%‬

Return on Equity

‪88.47%‬

Ownership

Shares Outstanding

63.95M

Float

33.94M

Short % of Shares Outstanding

‪13.20%‬

Held by Insiders

‪46.90%‬

Held by Institutions

‪49.33%‬

Price stats

Beta

‪0.87‬

50-Day Avg

‪214.40‬

200-Day Avg

‪161.20‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Hold

8 analysts

Average price target

‪$ 218.43‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 16, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - DVA - DaVita Inc.

Peers - DVA - DaVita Inc.

Peer Comparison

Compared with companies in Medical Care Facilities listed on NYSE.

Profile Summary - DVA - DaVita Inc.

About

DaVita Inc. is a leading healthcare provider specializing in kidney care services for patients with chronic kidney failure. The company operates primarily through its US Dialysis and Related Lab Services segment, delivering dialysis treatments at outpatient facilities across the United States, complemented by…

SectorHealthcare
IndustryMedical Care Facilities
Employees78K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.